Literature DB >> 32176317

Validation of the 34-week gestation as definition of late onset preeclampsia: Testing different cutoffs from 30 to 37 weeks on a population-based cohort of 1700 preeclamptics.

Pierre-Yves Robillard1,2, Gustaaf Dekker3, Marco Scioscia4, Francesco Bonsante1,2, Silvia Iacobelli1,2, Malik Boukerrou2,5, Thomas C Hulsey6.   

Abstract

INTRODUCTION: Early onset preeclampsia (EOP) and late onset preeclampsia (LOP) have been differentiated with a cut-point of ≤34 weeks. This classical definition has never been examined with respect to maternal characteristics by different gestational age cut-points. We examined maternal characteristics in a population-based cohort of 1736 preeclamptic deliveries at different gestational age cut-points from 30 to 37 weeks (CO30 to CO37).
MATERIAL AND METHODS: Eighteen-year observational population-based historical cohort study (2001-2018). All consecutive births delivered at the Centre Hospitalier Universitaire Hospitalier Sud Reunion's maternity. Standardized epidemiological perinatal database.
RESULTS: The incidence of EOP was lower in adolescents (1.8% vs 3.5%, odds ratio [OR] 0.50, P = .17). Conversely, the odds of LOP was increased for women over 35, beginning at C030 (OR 1.13, P = .02) and this effect (OR = 1.2) was still detectable at C037 (P = .06). Among primigravid women, the incidence of EOP was lower than LOP (OR ranging from 0.71 to 0.82 for different CO). Conversely, the incidence of LOP was higher (adjusted OR about 2.7 [CO30-CO34] with a rise to 3.3 at CO37 (P < .001). Women with EOP had a lower body mass index (BMI) as compared with LOP at CO34 and CO37. The adjusted OR (per 5 kg/m2 increment) declined from 1.06 to 1.03 from CO30 to C037 in EOP women. Conversely, for LOP, the adjusted odds ratio (aOR) increased from 1.04 to 1.06 from CO30 to CO37 (P < .001). Gestational diabetes mellitus was not associated with LOP at any cut-off (aOR 1.07, NS) but was protective against EOP from CO30 to CO34 (aOR 0.42, 0.61 and 0.73, respectively, P < .001). This protective effect disappeared at CO37. Chronic hypertension and history of preeclampsia were both EOP and LOP risks but with a much stronger effect for EOP (chronic hypertension: aOR 6.0-6.5, history of preeclampsia: aOR 12-17).
CONCLUSIONS: The 34th week of gestation appears to provide a reasonable cut-point to differentiate between EOP and LOP. Additional research is needed to better describe the possible differences in the pathophysiology of these different phenotypes.
© 2020 Nordic Federation of Societies of Obstetrics and Gynecology (NFOG). Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  early onset preeclampsia; epidemiology; late onset preeclampsia; preeclampsia

Mesh:

Year:  2020        PMID: 32176317      PMCID: PMC7492422          DOI: 10.1111/aogs.13846

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  19 in total

1.  The interval between pregnancies and preeclampsia.

Authors:  Audrey F Saftlas; Richard J Levine
Journal:  N Engl J Med       Date:  2002-06-06       Impact factor: 91.245

Review 2.  The birth interval hypothesis-does it really indicate the end of the primipaternity hypothesis.

Authors:  Gus Dekker; Pierre Yves Robillard
Journal:  J Reprod Immunol       Date:  2003-08       Impact factor: 4.054

Review 3.  Heterogeneous causes constituting the single syndrome of preeclampsia: a hypothesis and its implications.

Authors:  R B Ness; J M Roberts
Journal:  Am J Obstet Gynecol       Date:  1996-11       Impact factor: 8.661

4.  Risk factors for pre-eclampsia in a large cohort of Latin American and Caribbean women.

Authors:  A Conde-Agudelo; J M Belizán
Journal:  BJOG       Date:  2000-01       Impact factor: 6.531

Review 5.  Historical evolution of ideas on eclampsia/preeclampsia: A proposed optimistic view of preeclampsia.

Authors:  Pierre-Yves Robillard; Gustaaf Dekker; Gérard Chaouat; Marco Scioscia; Silvia Iacobelli; Thomas C Hulsey
Journal:  J Reprod Immunol       Date:  2017-09-18       Impact factor: 4.054

6.  Maternal allergy as an isolated risk factor for early-onset preeclampsia: An epidemiological study.

Authors:  Anne Kvie Sande; Erik Andreas Torkildsen; Ragnar Kvie Sande; Nils-Halvdan Morken
Journal:  J Reprod Immunol       Date:  2018-04-20       Impact factor: 4.054

7.  The definition of severe and early-onset preeclampsia. Statements from the International Society for the Study of Hypertension in Pregnancy (ISSHP).

Authors:  Andrea L Tranquilli; Mark A Brown; Gerda G Zeeman; Gustaaf Dekker; Baha M Sibai
Journal:  Pregnancy Hypertens       Date:  2012-11-30       Impact factor: 2.899

8.  Association between gestational diabetes and pregnancy-induced hypertension.

Authors:  Chris L Bryson; George N Ioannou; Stephen J Rulyak; Cathy Critchlow
Journal:  Am J Epidemiol       Date:  2003-12-15       Impact factor: 4.897

9.  An essay of reflection: Why does preeclampsia exist in humans, and why are there such huge geographical differences in epidemiology?

Authors:  Pierre-Yves Robillard; Gustaaf Dekker; Silvia Iacobelli; Gérard Chaouat
Journal:  J Reprod Immunol       Date:  2015-07-11       Impact factor: 4.054

10.  Increased BMI has a linear association with late-onset preeclampsia: A population-based study.

Authors:  Pierre-Yves Robillard; Gustaaf Dekker; Marco Scioscia; Francesco Bonsante; Silvia Iacobelli; Malik Boukerrou; Thomas C Hulsey
Journal:  PLoS One       Date:  2019-10-17       Impact factor: 3.240

View more
  3 in total

Review 1.  Galectins in Early Pregnancy and Pregnancy-Associated Pathologies.

Authors:  Milica Jovanović Krivokuća; Aleksandra Vilotić; Mirjana Nacka-Aleksić; Andrea Pirković; Danica Ćujić; Janko Legner; Dragana Dekanski; Žanka Bojić-Trbojević
Journal:  Int J Mol Sci       Date:  2021-12-22       Impact factor: 5.923

2.  The Role of Inorganics in Preeclampsia Assessed by Multiscale Multimodal Characterization of Placentae.

Authors:  Thomas Rduch; Elena Tsolaki; Yassir El Baz; Sebastian Leschka; Diana Born; Janis Kinkel; Alexandre H C Anthis; Tina Fischer; Wolfram Jochum; René Hornung; Alexander Gogos; Inge K Herrmann
Journal:  Front Med (Lausanne)       Date:  2022-03-30

Review 3.  Galectins: Important Regulators in Normal and Pathologic Pregnancies.

Authors:  Min Chen; Jia-Lu Shi; Zi-Meng Zheng; Zhi Lin; Ming-Qing Li; Jun Shao
Journal:  Int J Mol Sci       Date:  2022-09-03       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.